MetaCap

Zentalis Pharmaceuticals Insider Trades

NASDAQ: ZNTLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.64+0.13 (+5.18%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $22.92M
Sales
10 · $10.11M
Shares bought / sold
10.79M / 7.56M
Net activity
Net buying $12.8 million

Zentalis Pharmaceuticals insider activity

Over the last 12 months, Zentalis Pharmaceuticals insiders reported 19 transactions on SEC Form 4: 2 open-market purchases and 10 sales. Insiders bought $22.9 million and sold $10.1 million worth of stock, for net insider buying of $12.8 million. The largest seller was Matrix Capital Management Company, LP & GOEL DAVID E., with $10.0 million in reported sales.

The most recent filing shows Bruns Ingmar (Chief Medical Officer) reporting a transaction in 9,727 shares at $2.18 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ZNTL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ZNTL insider transactions

Zentalis Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026Bruns IngmarChief Medical OfficerAward9,727$21.20KForm 4
Aug 14, 2026WALTERS GROUP & WALTERS WILLIAM THURMAN & WALTERS SUSAN BERKLEY10% OwnerBuy4,335,000$15.17MForm 4
Jun 16, 2026Myers Scott DunsethDirectorAward57,100—Form 4
Jun 16, 2026Kariuki EnochDirectorAward57,100—Form 4
Jun 16, 2026Skvarka JanDirectorAward57,100—Form 4
Jun 16, 2026Johnson David MichaelDirectorAward57,100—Form 4
Jun 16, 2026Walker Luke NathanielDirectorAward57,100—Form 4
May 26, 2026Campbell ShannonDirectorAward114,200—Form 4
Feb 10, 2026Vultaggio VincentPAO and PFOSale6,894$16.70KForm 4
Feb 9, 2026EASTLAND JULIA MARIECEO & PresidentSale889$2.13KForm 4
Feb 9, 2026Bruns IngmarChief Medical OfficerSale335$801.62Form 4
Feb 9, 2026Vultaggio VincentPAO and PFOSale3,379$8.09KForm 4
Feb 6, 2026EASTLAND JULIA MARIECEO & PresidentSale7,866$19.11KForm 4
Feb 6, 2026Bruns IngmarChief Medical OfficerSale2,962$7.20KForm 4
Feb 6, 2026Vultaggio VincentPAO and PFOSale29,951$72.77KForm 4
Feb 3, 2026Vultaggio VincentPAO and PFOSale556$1.40KForm 4
Feb 2, 2026Vultaggio VincentPAO and PFOSale2,540$6.48KForm 4
Dec 31, 2025WALTERS GROUP & WALTERS WILLIAM THURMAN & WALTERS SUSAN BERKLEY10% OwnerBuy6,459,973$7.75MForm 4
Dec 15, 2025Matrix Capital Management Company, LP & GOEL DAVID E.10% OwnerSale7,500,000$9.97MForm 4
Jun 17, 2025Myers Scott DunsethDirectorAward57,603—Form 4
Jun 17, 2025Kariuki EnochDirectorAward57,603—Form 4
Jun 17, 2025Johnson David MichaelDirectorAward57,603—Form 4
Jun 17, 2025Skvarka JanDirectorAward57,603—Form 4
Jun 17, 2025Walker Luke NathanielDirectorAward57,603—Form 4
Apr 30, 2025Myers Scott DunsethDirectorBuy21,000$29.37KForm 4
Feb 6, 2025Bruns IngmarChief Medical OfficerBuy20,000$45.66KForm 4
Feb 3, 2025EASTLAND JULIA MARIECEO & PresidentAward59,388—Form 4
Feb 3, 2025Bruns IngmarChief Medical OfficerAward16,629—Form 4
Feb 3, 2025Lackner MarkChief Scientific OfficerSale14,368$24.59KForm 4
Feb 3, 2025Lackner MarkChief Scientific OfficerAward335,907—Form 4
Feb 3, 2025Vultaggio VincentPAO and Interim PFOSale2,615$4.48KForm 4
Feb 3, 2025Vultaggio VincentPAO and Interim PFOAward158,586—Form 4
Feb 3, 2025Paul AndreaChief Legal OfficerSale13,230$22.64KForm 4
Feb 3, 2025Paul AndreaChief Legal OfficerAward934,041—Form 4
Jan 31, 2025EASTLAND JULIA MARIECEO & PresidentBuy28,500$49.34KForm 4
Jan 31, 2025Walker Luke NathanielDirectorBuy14,200$24.97KForm 4
Jan 31, 2025Skvarka JanDirectorBuy60,000$103.45KForm 4
Jan 2, 2025Lackner MarkChief Scientific OfficerSale4,411$13.76KForm 4
Nov 13, 2024Myers Scott DunsethDirectorAward260,192—Form 4
Oct 4, 2024Vultaggio VincentPrincipal Accounting OfficerSale1,603$5.10KForm 4
Jun 21, 2024Skvarka JanDirectorAward41,581—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related